{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:27:49Z","timestamp":1787023669431,"version":"build-2736575974"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T00:00:00Z","timestamp":1782259200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T00:00:00Z","timestamp":1782259200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the Project of Technology Department in Sichuan Provinc","award":["2020YJ0187"],"award-info":[{"award-number":["2020YJ0187"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s10067-026-08232-6","type":"journal-article","created":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T23:28:18Z","timestamp":1782257298000},"page":"5023-5031","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Urate-lowering therapy adherence among gout patients in Southwest China: A cross-sectional study of determinants and regional disparities"],"prefix":"10.1007","volume":"45","author":[{"given":"Zhenboyang","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangqiang","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangliang","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiru","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiqiang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5696-9070","authenticated-orcid":false,"given":"Jie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,24]]},"reference":[{"key":"8232_CR1","doi-asserted-by":"publisher","first-page":"762820","DOI":"10.1155\/2015\/762820","volume":"2015","author":"R Liu","year":"2015","unstructured":"Liu R, Han C, Wu D et al (2015) Prevalence of hyperuricemia and gout in mainland China from 2000 to 2014: A Systematic Review and Meta-Analysis. Biomed Res Int 2015:762820","journal-title":"Biomed Res Int"},{"issue":"4","key":"8232_CR2","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1136\/annrheumdis-2013-204463","volume":"74","author":"CF Kuo","year":"2015","unstructured":"Kuo CF, Grainge MJ, Mallen C et al (2015) Rising burden of gout in the UK but continuing suboptimal management: a nationwide population study. Ann Rheum Dis 74(4):661\u2013667","journal-title":"Ann Rheum Dis"},{"key":"8232_CR3","doi-asserted-by":"crossref","unstructured":"Fitzgerald (2020) Testing for the HLA-B*5801 allele prior to starting allopurinol is conditionally recommended for patients of Southeast Asian descent (e.g., Han Chinese, Korean, Thai) and for African American patients (vol, pg 744, 2020). Arthritis Care Res 72(8):1187\u20131187","DOI":"10.1002\/acr.24401"},{"issue":"3","key":"8232_CR4","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1002\/art.20405","volume":"51","author":"A Shoji","year":"2004","unstructured":"Shoji A, Yamanaka H, Kamatani N (2004) A retrospective study of the relationship between serum urate level and recurrent attacks of gouty arthritis: evidence for reduction of recurrent gouty arthritis with antihyperuricemic therapy. Arthritis Rheum 51(3):321\u2013325","journal-title":"Arthritis Rheum"},{"issue":"8","key":"8232_CR5","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1093\/rheumatology\/kem056a","volume":"46","author":"KM Jordan","year":"2007","unstructured":"Jordan KM, Cameron JS, Snaith M et al (2007) British Society for Rheumatology and British Health Professionals in Rheumatology guideline for the management of gout. Rheumatology (Oxford) 46(8):1372\u20131374","journal-title":"Rheumatology (Oxford)"},{"issue":"10","key":"8232_CR6","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1136\/ard.2006.055269","volume":"65","author":"W Zhang","year":"2006","unstructured":"Zhang W, Doherty M, Bardin T et al (2006) EULAR evidence based recommendations for gout.: part II:: management.: report of a task force of the EULAR standing committee for international clinical studies including therapeutics (ESCISIT). Ann Rheum Dis 65(10):1312\u20131324","journal-title":"Ann Rheum Dis"},{"issue":"21","key":"8232_CR7","doi-asserted-by":"publisher","first-page":"2857","DOI":"10.1001\/jama.289.21.2857","volume":"289","author":"KT Rott","year":"2003","unstructured":"Rott KT, Agudelo CA (2003) Gout. JAMA 289(21):2857\u20132860","journal-title":"JAMA"},{"issue":"9711","key":"8232_CR8","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/S0140-6736(09)60883-7","volume":"375","author":"P Richette","year":"2010","unstructured":"Richette P, Bardin T (2010) Gout Lancet 375(9711):318\u2013328","journal-title":"Gout Lancet"},{"issue":"10","key":"8232_CR9","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1002\/acr.22336","volume":"66","author":"MA De Vera","year":"2014","unstructured":"De Vera MA, Marcotte G, Rai S et al (2014) Medication adherence in gout: a systematic review. Arthritis Care Res 66(10):1551\u20131559","journal-title":"Arthritis Care Res"},{"issue":"2","key":"8232_CR10","doi-asserted-by":"publisher","first-page":"R82","DOI":"10.1186\/ar4524","volume":"16","author":"JA Singh","year":"2014","unstructured":"Singh JA (2014) Facilitators and barriers to adherence to urate-lowering therapy in African-Americans with gout: a qualitative study. Arthritis Res Ther 16(2):R82","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"8232_CR11","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1592\/phco.28.4.437","volume":"28","author":"BA Briesacher","year":"2008","unstructured":"Briesacher BA, Andrade SE, Fouayzi H et al (2008) Comparison of drug adherence rates among patients with seven different medical conditions. Pharmacotherapy 28(4):437\u2013443","journal-title":"Pharmacotherapy"},{"key":"8232_CR12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0129364","author":"T van Mierlo","year":"2015","unstructured":"van Mierlo T, Fournier R, Ingham M (2015) Targeting medication non-adherence behavior in selected autoimmune diseases: a systematic approach to digital health program development. PLoS ONE. https:\/\/doi.org\/10.1371\/journal.pone.0129364","journal-title":"PLoS ONE"},{"issue":"6","key":"8232_CR13","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1007\/s10067-013-2168-8","volume":"32","author":"PC Robinson","year":"2013","unstructured":"Robinson PC, Schumacher HR (2013) A qualitative and quantitative analysis of the characteristics of gout patient education resources. Clin Rheumatol 32(6):771\u2013778","journal-title":"Clin Rheumatol"},{"issue":"8","key":"8232_CR14","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1136\/ard.2008.092619","volume":"68","author":"JA Singh","year":"2009","unstructured":"Singh JA, Hodges JS, Asch SM (2009) Opportunities for improving medication use and monitoring in gout. Ann Rheum Dis 68(8):1265\u20131270","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"8232_CR15","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1111\/j.1524-4733.2008.00400.x","volume":"12","author":"S Kripalani","year":"2009","unstructured":"Kripalani S, Risser J, Gatti ME et al (2009) Development and evaluation of the Adherence to Refills and Medications Scale (ARMS) among low-literacy patients with chronic disease. Value in Health 12(1):118\u2013123","journal-title":"Value in Health"},{"key":"8232_CR16","doi-asserted-by":"publisher","first-page":"213","DOI":"10.2147\/PPA.S236268","volume":"14","author":"YJ Chen","year":"2020","unstructured":"Chen YJ, Chang J, Yang SY (2020) Psychometric evaluation of Chinese version of Adherence to Refills and Medications Scale (ARMS) and blood-pressure control among elderly with hypertension. Patient Prefer Adherence 14:213\u2013220","journal-title":"Patient Prefer Adherence"},{"issue":"2","key":"8232_CR17","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1177\/0145721716632062","volume":"42","author":"CJ Kim","year":"2016","unstructured":"Kim CJ, Park E, Schlenk EA et al (2016) Psychometric evaluation of a Korean version of the Adherence to Refills and Medications Scale (ARMS) in adults with type 2 diabetes. Diabetes Educ 42(2):188\u2013198","journal-title":"Diabetes Educ"},{"issue":"9","key":"8232_CR18","doi-asserted-by":"publisher","first-page":"2943","DOI":"10.1007\/s10067-024-07050-y","volume":"43","author":"M Schulz","year":"2024","unstructured":"Schulz M, Day RO, Coleshill MJ et al (2024) Psychometric evaluation of the Adherence to Refills and Medications Scale (ARMS) in Australians living with gout. Clin Rheumatol 43(9):2943\u20132954","journal-title":"Clin Rheumatol"},{"issue":"7","key":"8232_CR19","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1007\/s00296-017-3746-x","volume":"37","author":"RL Yin","year":"2017","unstructured":"Yin RL, Cao HX, Fu T et al (2017) The rate of adherence to urate-lowering therapy and associated factors in Chinese gout patients: a cross-sectional study. Rheumatol Int 37(7):1187\u20131194","journal-title":"Rheumatol Int"},{"key":"8232_CR20","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000008532","author":"F Sheng","year":"2017","unstructured":"Sheng F, Fang WG, Zhang BQ et al (2017) Adherence to gout management recommendations of Chinese patients. Medicine (Baltimore). https:\/\/doi.org\/10.1097\/MD.0000000000008532","journal-title":"Medicine (Baltimore)"},{"key":"8232_CR21","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.2147\/PPA.S227329","volume":"13","author":"G Reach","year":"2019","unstructured":"Reach G, Chenuc G, Maigret P et al (2019) Implication of character traits in adherence to treatment in people with gout: a reason for considering nonadherence as a syndrome. Patient Prefer Adherence 13:1913\u20131926","journal-title":"Patient Prefer Adherence"},{"issue":"9","key":"8232_CR22","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1093\/rheumatology\/key155","volume":"57","author":"L Scheepers","year":"2018","unstructured":"Scheepers L, Burden AM, Arts ICW et al (2018) Medication adherence among gout patients initiated allopurinol: a retrospective cohort study in the Clinical Practice Research Datalink (CPRD). Rheumatology 57(9):1641\u20131650","journal-title":"Rheumatology"},{"issue":"6","key":"8232_CR23","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1093\/rheumatology\/kes431","volume":"52","author":"G Zandman-Goddard","year":"2013","unstructured":"Zandman-Goddard G, Amital H, Shamrayevsky N et al (2013) Rates of adherence and persistence with allopurinol therapy among gout patients in Israel. Rheumatology (Oxford) 52(6):1126\u20131131","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"8232_CR24","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1007\/s40744-020-00249-w","volume":"7","author":"F Perez-Ruiz","year":"2020","unstructured":"Perez-Ruiz F, Perez-Herrero N, Richette P et al (2020) High rate of adherence to urate-lowering treatment in patients with gout: who\u2019s to blame? Rheumatol Ther 7(4):1011\u20131019","journal-title":"Rheumatol Ther"},{"issue":"7","key":"8232_CR25","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1002\/acr.22785","volume":"68","author":"BW Coburn","year":"2016","unstructured":"Coburn BW, Bendlin KA, Sayles H et al (2016) Target serum urate: do gout patients know their goal? Arthritis Care Res (Hoboken) 68(7):1028\u20131035","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"11","key":"8232_CR26","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1007\/s10067-013-2333-0","volume":"32","author":"QH Li","year":"2013","unstructured":"Li QH, Dai L, Li ZX et al (2013) Questionnaire survey evaluating disease-related knowledge for 149 primary gout patients and 184 doctors in South China. Clin Rheumatol 32(11):1633\u20131640","journal-title":"Clin Rheumatol"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-026-08232-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-026-08232-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-026-08232-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:17:17Z","timestamp":1787023037000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-026-08232-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,24]]},"references-count":26,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["8232"],"URL":"https:\/\/doi.org\/10.1007\/s10067-026-08232-6","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,24]]},"assertion":[{"value":"3 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The present study protocol was reviewed and approved by the Ethics Committee of the Affiliated Hospital of Southwest Medical University (Approval No. KY2021022). All methods were performed in accordance with relevant guidelines and regulations. Written informed consent was obtained from all participants prior to study inclusion.","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}}]}}